Skip to main content
. Author manuscript; available in PMC: 2019 May 16.
Published in final edited form as: Mol Cancer Ther. 2002 Oct;1(12):1089–1095.

Fig. 4.

Fig. 4.

Cytotoxic effect of Adriamycin (A), cisplatin (B), and TLK286 (C) on Adriamycin-sensitive (■) and resistant human leukemia cell lines (▲). Five × 103 cells/100 µl were dispensed into 96-well plates. After incubation for 72 h in the presence of indicated concentrations of Adriamycin, cisplatin, or TLK286, cell viability was determined using MTS reagents. Data are the mean of three experiments; bars, ±SD.